Upload
jefry-alfarizy
View
216
Download
0
Embed Size (px)
DESCRIPTION
Must to know
Citation preview
Ita ArmyantiFarmakologi PSPD FK
UNTAN
Apr 28, 2023 1Muskuloskeletal2013
1. Sebutkan 2 contoh obat yang termasuk dalam NSAIDs, beserta mekanisme kerjanya
2. Sebutkan 2 efek samping yg sering tjd akibat pemakaian NSAIDs
3. Sebutkan 2 indikasi NSAIDs
Apr 28, 2023muskuloskeletal2012 2
Menghambat sintesis PG : produk dr COX
Prostaglandins are arachidonic acid metabolites.
Arachidonic acid is a fatty acid released from membrane phospholipids by the actions of phospholipase A2It can also be released by the combination phospholipase C and diglyceride lipase.
Apr 28, 2023 3muskuloskeletal2012
Apr 28, 2023muskuloskeletal2012 4
1. Cycloogygenase-1 (Cox-1):• It is constitutively expressed• Widely distributed and has a
“housekeeping” function. e.g gastric cytoprotection
2. Cycloogygenase-2 (Cox-2):• Inducible• Is an immediate early response
gene product in inflammatory & immune cells
Apr 28, 2023 5muskuloskeletal2012
Expression is 10-18 fold stimulated by growth factors, tumor promoters, cytokines and lipopolysaccaride endotoxin.
Inhibited by dexamethasone Involved in normal development Involved in vascular prostacyclin
production.
Apr 28, 2023 6muskuloskeletal2012
Membrane Phospholipids
Arachidonic acid
Cyclic endoperoxides
Phospholipase A2
Phospholipase C
Diglyceride lipase
CyclooxygenaseLipooxygenase
LTs
PGI2 TXA2
PGD2PGE2
PGF2α
PGI synthase Thromboxane synthase
PGE synthase
PGDsynthase
PGE9-KetoreductaseApr 28, 2023 7muskuloskeletal2012
LTA4
LTB4 LTC4
LTD4
LTE4
1. Phagocyte activation
2. ChemotaxisBronchoconstriction
Apr 28, 2023 8muskuloskeletal2012
PGI2:1. Vasodilation2. Inhibition of platelet aggregation3. Bronchodilation4. Glomerular filtration TXA2:1. Vasoconstriction2. Stimulation of platelet aggregation3. Is a smooth muscle mitogen4. Intrarenal vasoconstriction during
inflammatory conditions of the kidney
Apr 28, 2023 9muskuloskeletal2012
PGE2:1. Vasodilation2. Patency of ductus arteriosus3. Bronchodilation4. Uterine contraction & dysmenorrhea5. Cervical ripening6. Decreased gastric acid secretion7. Pain sensitization8. Increased body temperature9. Stimulate longitudinal muscle in GIT10. Increase glomerular filtration
Apr 28, 2023 10muskuloskeletal2012
PGF2α:1. Vasoconstriction2. Bronchoconstriction3. Uterine contraction4. Aqueous humor drainage5. Contracts circular muscle in GIT PGD2:1. Bronchoconstriction2. Vasodilation or vasoconstriction3. Natural sleep
Apr 28, 2023 11muskuloskeletal2012
1. Alprostadil (PGE1 analogue):Used to maintain patency of the ductus arteriosus in infants with congenital heart disease – waiting for surgical correction
2. Carboprost (PGF2α analogue):a. To terminate pregnancyb. To control refractory postpartum bleeding
Apr 28, 2023 12muskuloskeletal2012
3. Misoprostol (PGE1 analogue):a. Used in combination with NSAIDs to decrease gastric acid secretion & to inhibit ulcerationb. Induction of laborc. Enhancing cervical ripeningd. Induction of abortion Associated with increased risk of uterine rupture and perforation
Apr 28, 2023 13muskuloskeletal2012
4. Dinoprostone (PGE2 analogue):Causes uterine contractions and is used to induce abortion during the second trimester and to empty the uterus following fetal death, missed abortion or benign hydatidiform mole.
5. Epoprostenol (PGI2 analogue):For primary pulmonary hypertension
6. Latanoprost (PGF2α analogue):For glaucoma
Apr 28, 2023 14muskuloskeletal2012
Involves the release of a number of mediators
Results in pain and tissue destruction
Treatment involves:1. Relief of pain2. Slowing tissue damage or3. Arresting tissue damage
Apr 28, 2023 15muskuloskeletal2012
Analgesic-antipyretic-antiinflammatory Drugs.
Chemically diverse group of compounds
All are weak organic acids except nabumetone which is a prodrug metabolized to an acidic active drug
Most are highly metabolizedApr 28, 2023 16muskuloskeletal2012
Broad range of pharmacokinetic characteristics
Most are highly ( > 98%) protein-bound
Used to treat muscle strain, tendinitis, bursitis, rheumatoid arthritis, osteoarthritis & ankylosing spondylitis
Antiinflammatory action is mediated via inhibition cycloxygenase-2 and thus PG synthesis
Apr 28, 2023 17muskuloskeletal2012
Most are reversible inhibitors of Coxs,except aspirin which irreversibly acetylates the active site of the enzyme1. Celecoxib, rofecoxib & valdecoxib are
selective Cox-2 inhibitors2. Aspirin, indomethacin, piroxicam &
sulindac are more effective on Cox-13. Ibuprofen & meclofenamic acid
inhibit the 2 isozymes equally
Apr 28, 2023 18muskuloskeletal2012
Is the prototype NSAID Use for inflammatory conditions is
now rare Mainly used as antiplatelet drugPharmacokinetics: Acetylsalicylic acid is rapidly
absorbed from the stomach and upper intestine
Is rapidly hydrolyzed to acetic acid and salicylate by esterases in tissues and blood
Apr 28, 2023 19muskuloskeletal2012
Salicylate is bound to albumin and binding is saturable
Eliminated by metabolism and elimination is zero-order (saturable)
t½ is dose-dependant:600 mg / day 3-5 hours> 3.6 g / day 12-16 hours
Alkalinization of urine increases rate of excretion of salicylates
Apr 28, 2023 20muskuloskeletal2012
A. Antiinflammatory: Nonselective inhibitor of both Cox
izozymes Nonacetylated salicylates may work as
oxygen radical scavengers Interfere with chemical mediators of
the kallikrein system, thus, inhibiting granulocyte adherence to the damaged vasculature, stabilizing lysosomes and inhibiting the chemotaxis of polymorphonuclear leukocytes and macrophages. Dose > 3.6 g
Apr 28, 2023 21muskuloskeletal2012
B. Analgesic effects:Reduces pain of mild-to-moderate severity through its effects on inflammation. It may also inhibit pain stimuli at a subcortical site
Apr 28, 2023 22muskuloskeletal2012
C. Antipyretic effects: Reduces elevated body temperature Antipyretic effect is probably mediated
by both COX inhibition in the CNS and inhibition of IL-1 (released from macrophages during inflammation . Dose ~ 600 mg
D. Antiplatelet effects: At single low dose (81 mg) daily due to
irreversible inhibition of platelet COX Effect lasts for the life of platelet (8-10
days)Apr 28, 2023 23muskuloskeletal2012
1. Gastric upset, peptic ulceration & upper GI bleeding. Fecal blood loss Iron deficiency anemia (less with COX-2 inhibitors)
2. Salicylism: At high & chronic dose.Vomiting, tinnitus, decreased hearing, deafness, vertigo, headache, nervousness, confusion, retinal disturbances
Apr 28, 2023 24muskuloskeletal2012
3. Toxic doses:• Respiratory alkalosis due to
hyperpnea through a direct effect on the medulla
• Followed by metabolic acidosis due to salicylate accumulation
• Respiratory depression• Cardiac toxicity• Glucose intolerance
Apr 28, 2023 25muskuloskeletal2012
4. Uric acid retention at doses of 2 g or less dailyUric acid excretion at daily doses of 4 g or more
5. Renal function impairment, fluid retention, interstitial nephritis, papillary necrosis
6. Elevation of liver enzymes, hepatic necrosis, cholestasis, hepatitis & Reye’s syndrome in children with febrile illness
Apr 28, 2023 26muskuloskeletal2012
7. Bleeding8. Allergic reactions: rash, asthma,
nasal polyps & anaphylaxis9. Hyperthermia: due to uncoupling
of oxidative phosphorylation10. Electrolyte disturbances11. Inhibition of uterine contractions
– delayed labor, low birth weight, premature closure of ductus arteriosus
12. Photosensitivity, toxic epidermal necrolysis
Apr 28, 2023 27muskuloskeletal2012
Very good analgesic and antipyretic
Used for:1. Musculoskeletal disorders PO,
IM2. Renal colic IM3. Dysmenorrhea IM4. Solar keratosis
TopicalApr 28, 2023 28muskuloskeletal2012
Salicylic acid derivative Zero-order kinetics Claimed to be particularly useful
for cancer pain with bone metastasis
Pain following dental surgery
Apr 28, 2023 29muskuloskeletal2012
Can be used orally or topically Less sodium and water retention
than others Less frequent GIT irritation or
bleeding AE : Aseptic meningitis particularly
in patients with SLE has been reported
Other adverse effects are similar Useful analgesic & antiinflammatory
Apr 28, 2023 30muskuloskeletal2012
May also inhibit phospholipases A & CReduces neutrophil migrationDecreases T cell and B cell proliferation
Probenecid prologs its half-life by inhibiting its biliary and renal secretion
Used in:1. Rheumatic conditions: Gout and
ankylosing spondylitis2. Patent ductus arteriosus Adverse effects occur in one third of
patients
Apr 28, 2023 31muskuloskeletal2012
Similar but more severe than other NSAIDs.
Headache (20%) + dizziness, confusion and depression
Psychosis, hallucinations Aplastic anemia, thrombocytopenia Hyperkalemia Diarrhea Pancreatitis
Apr 28, 2023 32muskuloskeletal2012
Has significant analgesic efficacy, used to replace morphine
Can be given IM, IV, PO Adverse effects similar to other
NSAIDs More renal toxicity
Apr 28, 2023 33muskuloskeletal2012
Prodrug t½ > 24 hours Less toxic to the stomach Adverse effects similar to NSAIDs May cause photosensitivity
Apr 28, 2023 34muskuloskeletal2012
Also inhibits polymorphonuclear leukocyte migration, decreases oxygen radical production and inhibits lymphocytes function
t½ very long ~ 57 hours Used for rheumatic conditions More toxic than other NSAIDs
Apr 28, 2023 35muskuloskeletal2012
Is a sulfoxide prodrug Metabolized into the active sulfide
metabolite Undergoes enterhepatic cycling,
like many other NSAIDs Indications similar to other NSAIDs
+1. Suppression of familial intestinal
polyposis2. May prevent development of
colon, breast and prostate cancerApr 28, 2023 36muskuloskeletal2012
Adverse effects similar to NSAIDs +1. Less nephrotoxic ( reoxidized to
the inactive prodrug in the kidney2. Steven Johnson syndrome,
epidermal necrolysis3. Thrombocytopenia,
agranulocytosis4. Nephrotic syndrome and reversible
renal failure5. Cholestatic hepatic damage
Apr 28, 2023 37muskuloskeletal2012
Celecoxib, Rofecoxib, Etoricoxib 10-20 X more selective
Meloxicam – preferential selection
Do not affect the constitutive form of COX significantly
Also has analgesic, antipyretic & antiinflammatory properties
Fewer GI adverse effectsApr 28, 2023 38muskuloskeletal2012
No impact on platelet aggregation, no cardiovascular protection
Renal toxicity similar to COX-1 inhibitors
Higher incidence of cardiovascular thrombotic events, hypertension, death from cardiac causes
Some of them were withdrawn from the market because of this adverse effect
Apr 28, 2023 39muskuloskeletal2012
1. GI bleeding and history of peptic ulceration
2. Advanced age, poor health, long duration of treatment & heavy alcohol use
3. Renal Impairment4. Heart failure, edema5. Hypertension6. Hypersensitivity reactions to
salicylates7. Bronchial asthma8. Pregnancy (?)
Apr 28, 2023 40muskuloskeletal2012
1. Corticosteroids: increased toxicity2. Biphosphonates: enhance GIT
irritation3. Anticoagulants including warfarin
(CYP2C9)4. Methotrexate: NSAIDs can decrease
its clearance severe hematologic and GI toxicity
5. Increase nephrotoxicity of aminoglycosides, amphotericin B, and other nephrotoxic agents
Apr 28, 2023 41muskuloskeletal2012
NSAIDs often offer symptomatic relief, reduce inflammation and pain and preserve function but have little effect on bone and cartilage destruction
DMARDs slow the progression and arrest the disease over 6 weeks to 6 months
Apr 28, 2023 42muskuloskeletal2012
Methotrexate Chlorambucil Cyclophosphamide Azathioprine Cyclosporine Mycophenolate mofetil
May be discussed later with anticancer drugs and immunosuppressants
Apr 28, 2023 43muskuloskeletal2012
Used mainly in the treatment of malaria and will be discussed more there
Antiinflammatory mechanism is unknown:
1. Suppression of T lymphocyte response to mitogens
2. Decreased leukocyte chemotaxis3. Stabilization of lysosomal enzymes4. Inhibition of DNA & RNA synthesis5. Trapping of free radicals
Apr 28, 2023 44muskuloskeletal2012
Extensively distributed to melanin-containing tissues
Indications:Rheumatoid arthritis: Takes 3-6 months to obtain a response
Adverse effects:1. Ocular toxicity2. Nightmares3. Dyspepsia
Apr 28, 2023 45muskuloskeletal2012
Rarely used because of toxicity Aurothiomalate and
Aurothioglucose IM Auranofin PO Mechanism of Action:
Alteration of morphology and function of macrophages: Inhibition of chemotactic factor-1, interleukin-8 and interleukin-1B production and vascular endothelium growth factor
Apr 28, 2023 46muskuloskeletal2012
Mechanism of Action (contd):IM gold compounds also alter lysosomal enzyme activity, reduce histamine release, inactivate the first component of complement and suppress phagocytic activity of polymorphonuclear leukocytesAuranofin also inhibits the release of PGE2 and LTB4.
Apr 28, 2023 47muskuloskeletal2012
Tends to concentrate in synovial membranes, liver, kidney, spleen, lymph nodes & bone marrow
t½ ~ 1 year Excreted in urine and feces Indications:
Active rheumatoid arthritis slows progression of the disease
Apr 28, 2023 48muskuloskeletal2012
Adverse effects:1. Pruritic skin rash and eosinophilia2. Stomatitis and metallic taste3. Thrombocytopenia, leukopenia,
pancytopenia and aplastic anemia4. Proteinuria, nephrotic syndrome5. Enterocolitis & cholestasis6. Peripheral neuropathy7. Pulmonary infiltrates8. Sweating, flushing & headache9. Corneal deposits
Apr 28, 2023 49muskuloskeletal2012
TNF-α and IL-1 are among the most important inflammatory cytokines
Are produced mainly by cells of the monocyte-macrophage lineage
Work in concert to stimulate inflammatory responses such as pain, fever and recruitment of lymphocytes
They also induce production of many other inflammatory mediators and contribute to tissue damage seen in chronic inflammation
Apr 28, 2023 50muskuloskeletal2012
Adalimumab, Infliximab, Etanercept Indicated for rheumatoid arthritis Main adverse effect is flare up of
macrophage-dependent infections such as tuberculosis and other opportunistic infections
Increased incidence of malignancies ???
Apr 28, 2023 51muskuloskeletal2012
Mechanism of action: It is converted to its active
metabolite in the intestine and plasma rapidly.
It inhibits dihydroorotate dehydrogenase reduced RNA synthesis and arrest of stimulated cells in G1 phase of cell growth Inhibition of T cell proliferation and production of autoantibodies by B cells
Apr 28, 2023 52muskuloskeletal2012
Completely absorbed after PO administration, t½ ~ 19 days
Indications: Rheumatoid arthritis, inhibits bone damage
Adverse effects:1. Diarrhea and elevation of liver
enzymes2. Mild alopecia3. Weight gain4. Increased blood pressure5. Leukopenia and thrombocytopenia6. Contraindicated in pregnancy
Apr 28, 2023 53muskuloskeletal2012
Analgesic-antipyretic but not antiinflammatory
Weak COX-1 and COX-2 inhibitor in peripheral tissues
Appears to inhibit COX-3 in the brain Pharmacokinetics:
Well absorbed following PO administrationMetabolized to glucuronide and sulfate conjugatest½ ~ 2-3 hours
Apr 28, 2023 54muskuloskeletal2012
Indications:1. Mild-to-moderate pain2. FeverAdverse effects: Safe at therapeutic doses Large doses dizziness, excitement &
disorientation Hepatic toxicity with centrilobular
necrosis due to accumulation of the metabolite N-acetyl-benzoquinoneimine.
May also produce acute renal tubular necrosis
Lethal dose 15 grams. Antidote: sulfhydryl (-SH) containing
agents such as N-acetylcysteineApr 28, 2023 55muskuloskeletal2012
Gout is a familial metabolic disease characterized by recurrent episodes of acute arthritis.
It is due to deposition of monosodium urate crystals in joints and cartilage
Usually associated with high serum levels of uric acid
Uric acid calculi may deposit in the kidney as part of the disease
Aims of treatment:1. Relief of acute gouty attack2. Prevention of recurrent gouty episodes
Apr 28, 2023 56muskuloskeletal2012
Mechanism of action:Binds the intracellular protein, tubulin, preventing its polymerization into microtubules inhibition of leukocyte migration and phagocytosis and cell mitosis.
It also inhibits the formation of LTB4
Apr 28, 2023 57muskuloskeletal2012
Pharmacodynamics:It rapidly relieves the pain and inflammation of gouty arthritis in 12-24 hoursNo direct analgesic effectNo effect on uric acid
Pharmacokinetics:Absorbed rapidly after oral administration and eliminated in urine and feces as metabolites
Apr 28, 2023 58muskuloskeletal2012
Therapeutic uses:1. Acute gouty arthritis2. Acute Mediterranean fever3. Sarcoid arthritis4. Hepatic cirrhosisAdverse Effects:1. Diarrhea, nausea, vomiting,
abdominal pain2. Hair loss
Apr 28, 2023 59muskuloskeletal2012
3. Bone marrow depression4. Peripheral neuritis5. Myopathy
Acute intoxication: burning throat pain, bloody diarrhea, shock, hematuria, oliguriaFatal ascending CNS depression
Apr 28, 2023 60muskuloskeletal2012
All can be used except aspirin, salicylates and tolmetin
Oxaprozin also increases uric acid excretion and should be avoided in urate renal stones
Apr 28, 2023 61muskuloskeletal2012
Probenecid (& sulfinpyrazone) Decrease body pool of uric acid by
increasing its excretionPharmacodynamics:
Uric acid is secreted and reabsorbed in the proximal renal tubules by active organic acid transport proteinsThese transport proteins are inhibited by probenecid, sulfinpyrazone and large doses of aspirin leading to decreased net reabsorption of uric acid Uric acid excretion
Apr 28, 2023 62muskuloskeletal2012
Therefore, the formation of uric acid renal stones may be increased. Thus fluid intake and alkalinization of urine is necessary to maintain urine flow and decrease precipitation of uric acid.
Pharmacokinetics:Probenecid is slowly metabolizedSulfinpyrazone is eliminated by the kidney
Apr 28, 2023 63muskuloskeletal2012
Adverse effects:1. GIT irritation (S > P)2. Skin rash and allergic
dermatitis (P > S)3. Nephrotic syndrome4. Aplastic anemia5. Renal stone formation
Apr 28, 2023 64muskuloskeletal2012
Inhibits xanthine oxidase and thus uric acid formation. It decreases plasma urate levels with a concurrent increase in the soluble xanthine and hypoxanthinePurine xanthine hypoxanthine uric acid
Pharmacokinetics: ~ 80 % absorbed after oral administration, metabolized also by xanthine oxidase to alloxanthine which is also an inhibitor of the enzyme
Apr 28, 2023 65muskuloskeletal2012
Uses:1. When uricosuric agents fail2. When urinary excretion of uric
acid is high3. Recurrent urate renal stone
formation4. To prevent massive uricosuria
following therapy of blood dyscrasia and cancer
Apr 28, 2023 66muskuloskeletal2012
Adverse effects:1. Acute attack of gouty arthritis
at the beginning of treatment which can be prevented by colchicine or NSAIDs
2. GIT: Nausea, vomiting, diarrhea3. Peripheral neuritis4. Necrotizing vasculitis5. Bone marrow depression
Apr 28, 2023 67muskuloskeletal2012
6. Hepatic toxicity7. Interstitial nephritis8. Allergic pruritic maculopapular
rash9. Exfoliative dermatitis10. CataractDrug interactions:
Inhibits the metabolism of mercaptopurine, azathioprine, warfarin, probenecid and cyclophosphamide
Apr 28, 2023 68muskuloskeletal2012
1. Sebutkan 2 contoh obat yang termasuk dalam NSAIDs, beserta mekanisme kerjanya
2. Sebutkan 2 efek samping yg sering tjd akibat pemakaian NSAIDs
3. Sebutkan 2 indikasi NSAIDs
Apr 28, 2023muskuloskeletal2012 69
Apr 28, 2023muskuloskeletal2012 70